Kodiak Sciences Inc. (KOD)
NASDAQ·Healthcare·Biotechnology
$45.50
+3.15%
Mkt Cap $2.44B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$1.02 | -$1.04 | -1.96% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$1.07 | -$1.16 | -8.41% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$1.01 | -$1.03 | -1.98% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.89 | -$1.09 | -22.47% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.90 | -$0.84 | +6.67% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.90 | -$0.84 | +6.67% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.87 | -$0.86 | +1.15% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$1.09 | -$0.82 | +24.77% | — | — |
| Q1 2024 Mar 28, 2024 | — | — | — | -$0.86 | -$1.13 | -31.40% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$1.41 | -$0.95 | +32.62% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$1.23 | -$1.53 | -24.39% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$1.28 | -$1.35 | -5.47% | — | — |
| Q1 2023 Mar 28, 2023 | — | — | — | -$1.58 | -$1.35 | +14.56% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$1.82 | -$1.47 | +19.23% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$1.77 | -$1.74 | +1.69% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$1.39 | -$1.83 | -31.65% | — | — |
| Q1 2022 Mar 1, 2022 | — | — | — | -$1.29 | -$1.79 | -38.76% | — | — |
| Q4 2021 Nov 9, 2021 | — | — | — | -$1.16 | -$1.30 | -12.07% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$1.04 | -$1.08 | -3.85% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$0.94 | -$0.98 | -4.26% | — | — |